← Evidence map

ReviewDrugs2020

Atezolizumab: A Review in Extensive-Stage SCLC.

James E FramptonPubMed ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

NCT06663098phase 2142 enrolled2025
Full record →Abstract, authors, funding and every citing paper · PMID 32990939